New Winning Strategies for Vitiligo: The Low Dose Cytokines TherapyApproach
作者： T Lotti , T Rivkina , M Kadurina
DOI: 10.4172/2376-0427.1000229
关键词:
摘要: Vitiligo is a dermatologic pigmentary disorder triggered by melanocytes’ loss and sustained deep immune imbalance which induce chronic inflammation excessive oxidative stress phenomena at skin level. Current therapies are mainly symptomatic designed in order to inhibit the inflammatory mediators vitiligo patches To restore correct balance between Th1/Th17 Th2/Treg response concomitantly rebalancing represents an innovative effective approach for treatment; Low Dose Medicine theories availability of specific low dose SKA interleukins, antibodies growth factors allows researchers clinicians act simultaneously against all main etiologic causes makes possible design new therapeutic approaches vitiligo.
omicsonline.org参考文章(19)
Ranjeeta Sapam, Sudha Agrawal, Tapan K. Dhali, Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study International Journal of Dermatology. ,vol. 51, pp. 1107- 1115 ,(2012) , 10.1111/J.1365-4632.2011.05454.X
Torello Lotti, Jana Hercogova, Giuseppe Fabrizi, Advances in the treatment options for vitiligo: activated low-dose cytokines-based therapy. Expert Opinion on Pharmacotherapy. ,vol. 16, pp. 2485- 2496 ,(2015) , 10.1517/14656566.2015.1087508
Elisabetta Radice, Graziella Bellone, Vincenzo Miranda, Enhancement of the Immunostimulatory Functions of Ex Vivo–Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study Translational Oncology. ,vol. 8, pp. 327- 338 ,(2015) , 10.1016/J.TRANON.2015.06.005
Victoria Barygina, Matteo Becatti, Torello Lotti, Silvia Moretti, Niccolò Taddei, Claudia Fiorillo, Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin Journal of Dermatological Science. ,vol. 79, pp. 163- 170 ,(2015) , 10.1016/J.JDERMSCI.2015.05.003
Manuel Sandoval-Cruz, Mario García-Carrasco, Renán Sánchez-Porras, Claudia Mendoza-Pinto, Mario Jiménez-Hernández, Pamela Munguía-Realpozo, Alejandro Ruiz-Argüelles, Immunopathogenesis of vitiligo. Autoimmunity Reviews. ,vol. 10, pp. 762- 765 ,(2011) , 10.1016/J.AUTREV.2011.02.004
Bi-Huan Xiao, Yan Wu, Yan Sun, Hong-Duo Chen, Xing-Hua Gao, Treatment of vitiligo with NB-UVB: A systematic review Journal of Dermatological Treatment. ,vol. 26, pp. 340- 346 ,(2015) , 10.3109/09546634.2014.952610
P. Li, H. Ma, D. Han, K. Mou, Interleukin‐33 affects cytokine production by keratinocytes in vitiligo Clinical and Experimental Dermatology. ,vol. 40, pp. 163- 170 ,(2015) , 10.1111/CED.12464
Surekha Tippisetty, Deepthi Goudi, Abdul Waheed Mohammed, Parveen Jahan, Repair efficiency and PUVA therapeutic response variation in patients with vitiligo Toxicology in Vitro. ,vol. 27, pp. 438- 440 ,(2013) , 10.1016/J.TIV.2012.08.003
Reinhart Speeckaert, Marijn M. Speeckaert, Nanja van Geel, Why treatments do(n't) work in vitiligo: An autoinflammatory perspective Autoimmunity Reviews. ,vol. 14, pp. 332- 340 ,(2015) , 10.1016/J.AUTREV.2014.12.003
Adriane Reichert Faria, Roberto Gomes Tarlé, Gerson Dellatorre, Marcelo Távora Mira, Caio Cesar Silva de Castro, Vitiligo--Part 2--classification, histopathology and treatment. Anais Brasileiros De Dermatologia. ,vol. 89, pp. 784- 790 ,(2014) , 10.1590/ABD1806-4841.20142717